Fig. 4From: Bapineuzumab for mild to moderate Alzheimer’s disease: a meta-analysis of randomized controlled trials Forest plot of mean difference (MD) in a CSF phosphorylated tau protein concentration, b Standardized uptake value ratio, measured by PIB-PET, and c MRI whole-brain volume measurementBack to article page